These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36047730)

  • 21. Clinical characteristics of KCNQ2 encephalopathy.
    Kim HJ; Yang D; Kim SH; Won D; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2021 Feb; 43(2):244-250. PubMed ID: 32917465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel KCNQ2 mutation in a large Emirati family with benign familial neonatal seizures.
    Saadeldin IY; Milhem RM; Al-Gazali L; Ali BR
    Pediatr Neurol; 2013 Jan; 48(1):63-6. PubMed ID: 23290024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homomeric Kv7.2 current suppression is a common feature in KCNQ2 epileptic encephalopathy.
    Gomis-Pérez C; Urrutia J; Marcé-Grau A; Malo C; López-Laso E; Felipe-Rucián A; Raspall-Chaure M; Macaya A; Villarroel A
    Epilepsia; 2019 Jan; 60(1):139-148. PubMed ID: 30478917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel de novo KCNQ2 mutation in a child with treatmentresistant early-onset epileptic encephalopathy.
    Benetou C; Papailiou S; Maritsi D; Anagnostopoulou K; Kontos H; Vartzelis G
    Turk J Pediatr; 2019; 61(2):279-281. PubMed ID: 31951342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
    Weckhuysen S; Mandelstam S; Suls A; Audenaert D; Deconinck T; Claes LR; Deprez L; Smets K; Hristova D; Yordanova I; Jordanova A; Ceulemans B; Jansen A; Hasaerts D; Roelens F; Lagae L; Yendle S; Stanley T; Heron SE; Mulley JC; Berkovic SF; Scheffer IE; de Jonghe P
    Ann Neurol; 2012 Jan; 71(1):15-25. PubMed ID: 22275249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
    Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
    Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A novel mutation in KCNQ2 gene causes benign familial infantile convulsions (BFIC) in a Chinese family].
    Zhou XH; Ma AQ; Liu XH; Huang C; Zhang YM; Shi RM
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):487-91. PubMed ID: 17044971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCNQ2 encephalopathy: A case due to a de novo deletion.
    Spagnoli C; Salerno GG; Iodice A; Frattini D; Pisani F; Fusco C
    Brain Dev; 2018 Jan; 40(1):65-68. PubMed ID: 28728838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phox2b-expressing neurons contribute to breathing problems in Kcnq2 loss- and gain-of-function encephalopathy models.
    Soto-Perez J; Cleary CM; Sobrinho CR; Mulkey SB; Carroll JL; Tzingounis AV; Mulkey DK
    Nat Commun; 2023 Dec; 14(1):8059. PubMed ID: 38052789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors.
    Kim EC; Patel J; Zhang J; Soh H; Rhodes JS; Tzingounis AV; Chung HJ
    Genes Brain Behav; 2020 Jan; 19(1):e12599. PubMed ID: 31283873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.
    Miceli F; Soldovieri MV; Ambrosino P; De Maria M; Migliore M; Migliore R; Taglialatela M
    J Neurosci; 2015 Mar; 35(9):3782-93. PubMed ID: 25740509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate.
    Soldovieri MV; Ambrosino P; Mosca I; De Maria M; Moretto E; Miceli F; Alaimo A; Iraci N; Manocchio L; Medoro A; Passafaro M; Taglialatela M
    Sci Rep; 2016 Dec; 6():38167. PubMed ID: 27905566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
    Abidi A; Devaux JJ; Molinari F; Alcaraz G; Michon FX; Sutera-Sardo J; Becq H; Lacoste C; Altuzarra C; Afenjar A; Mignot C; Doummar D; Isidor B; Guyen SN; Colin E; De La Vaissière S; Haye D; Trauffler A; Badens C; Prieur F; Lesca G; Villard L; Milh M; Aniksztejn L
    Neurobiol Dis; 2015 Aug; 80():80-92. PubMed ID: 26007637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.
    Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism.
    Miceli F; Millevert C; Soldovieri MV; Mosca I; Ambrosino P; Carotenuto L; Schrader D; Lee HK; Riviello J; Hong W; Risen S; Emrick L; Amin H; Ville D; Edery P; de Bellescize J; Michaud V; Van-Gils J; Goizet C; Willemsen MH; Kleefstra T; Møller RS; Bayat A; Devinsky O; Sands T; Korenke GC; Kluger G; Mefford HC; Brilstra E; Lesca G; Milh M; Cooper EC; Taglialatela M; Weckhuysen S
    EBioMedicine; 2022 Jul; 81():104130. PubMed ID: 35780567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathology findings in KCNQ2 neonatal epileptic encephalopathy.
    Legros L; Adle-Biassette H; Dozières-Puyravel B; Khung S; Elmaleh-Bergès M; Lesca G; Delanoë C; Biran V; Auvin S
    Seizure; 2022 Jul; 99():36-39. PubMed ID: 35584591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biallelic variants of KCNQ2 in early infantile developmental and epileptic encephalopathy.
    Zhang YJ; Wang TS; Zhu XM; Yu LF; Zhang LM; Zhou YF; Wang Y; Zhou SZ
    Seizure; 2024 Mar; 116():159-161. PubMed ID: 36934001
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel mutation in KCNQ2 causing benign familial neonatal seizures.
    Goldberg-Stern H; Kaufmann R; Kivity S; Afawi Z; Heron SE
    Pediatr Neurol; 2009 Nov; 41(5):367-70. PubMed ID: 19818940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy.
    Monni L; Kraus L; Dipper-Wawra M; Soares-da-Silva P; Maier N; Schmitz D; Holtkamp M; Fidzinski P
    Br J Pharmacol; 2022 Jan; 179(1):84-102. PubMed ID: 34605012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.
    Lee IC; Chang TM; Liang JS; Li SY
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00816. PubMed ID: 31199083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.